58.05
Schlusskurs vom Vortag:
$55.99
Offen:
$56.3
24-Stunden-Volumen:
594.82K
Relative Volume:
0.65
Marktkapitalisierung:
$4.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.13%
1M Leistung:
+21.85%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Vergleichen Sie HNGE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HNGE
Hinge Health Inc
|
58.05 | 4.37B | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
2025-06-16 | Eingeleitet | Barclays | Overweight |
2025-06-16 | Eingeleitet | BofA Securities | Buy |
2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
2025-06-16 | Eingeleitet | Needham | Buy |
2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
2025-06-16 | Eingeleitet | Raymond James | Outperform |
2025-06-16 | Eingeleitet | Stifel | Buy |
2025-06-16 | Eingeleitet | Truist | Buy |
2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health Announces Early Share Lock-Up Release - TipRanks
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Baron Small Cap Fund is Excited to Invest in Hinge Health (HNGE). Here’s Why - Insider Monkey
Is hnge a buy sell or hold - AInvest
Hinge Health (NYSE:HNGE) Shares Down 7.1%Should You Sell? - MarketBeat
Hinge Health (NYSE:HNGE) Price Target Raised to $65.00 - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Hinge Health (NYSE:HNGE) Given New $60.00 Price Target at Evercore ISI - MarketBeat
Morgan Stanley Raises Hinge Health (NYSE:HNGE) Price Target to $57.00 - MarketBeat
Bank of America Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health shares fall 1.26% intraday as Trump's import taxes raise economic concerns. - AInvest
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $49.86 - Defense World
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00 - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health price target raised to $62 from $48 at Truist - Yahoo Finance
Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald - TipRanks
Hinge Health (NYSE:HNGE) Sets New 52-Week High on Analyst Upgrade - Defense World
Hinge Health: Is It Too Late to Buy? - timothysykes.com
Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective - TipRanks
Hinge Health shares rise 23.34% intraday after RBC raised its price target to $60. - AInvest
TR | OpenAI4o Initiates Hinge Health(HNGE.US) With Hold Rating, Announces Target Price $52 - 富途牛牛
Hinge Health's Q2 Earnings Surge: A Case Study in Long-Term Value Creation Post-IPO - AInvest
Hinge Health's Q2 Earnings: A Strategic Bet on AI-Driven Healthcare Automation - AInvest
Hinge Health Q2 beat: 'Long-term' thinking is key, CEO says - Yahoo Finance
Hinge Health's AI-Driven Surge: Redefining Digital Healthcare Profitability Post-IPO - AInvest
Hinge Health beats Wall Street expectations on revenue in first public earnings - Healthcare Dive
Hinge Health price target raised to $63 from $55 at Stifel - TipRanks
Hinge Health Climbs Amidst Strategic Acquisitions and Expanding Horizons - StocksToTrade
Hinge Health price target raised to $59 from $47 at Needham - TipRanks
Elevating Dynamics: Hinge Health’s Strategic Moves Stir Market Pattens - timothysykes.com
Hinge Health's Post-IPO Surge: Clinical Excellence and Employer Adoption Fuel a New Era in Digital MSK Care - AInvest
Hinge Health Gains in Market Debut, Providing a Favorable Sign for IPOs -- Update - 富途牛牛
Hinge Health Soars 22.7% on Q2 Earnings Surge: Can This AI-Powered Healthcare Play Sustain Momentum? - AInvest
Why are Hinge Health’s Shares Surging in Premarket Trading Today? - Tokenist
RBC Raises Price Target on Hinge Health to $60 From $45, Keeps Outperform Rating - MarketScreener
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Hinge Health price target raised to $57 from $46 at Morgan Stanley - TipRanks
Stifel raises Hinge Health stock price target to $63 on strong Q2 results - Investing.com Nigeria
Hinge Health shares rise 7.84% premarket after Q2 2025 earnings call and revenue growth. - AInvest
Citizens JMP raises Hinge Health stock price target to $65 on strong earnings - Investing.com Australia
Hinge Health Reports Strong Q2 2025 Growth - TipRanks
Hinge Health's Q2 2025 Earnings: A Blueprint for Scalable AI-Driven Healthcare Growth - AInvest
Hinge Health Q2 Earnings: Revenue Beats Expectations, EPS Misses - AInvest
Hinge Health, Inc. shares rise 5.13% after-hours following Q3 revenue range expectations. - AInvest
Hinge Health's 52% Revenue Surge: How AI-Powered Care is Reshaping Digital Health Economics - AInvest
Hinge Health Reports Strong Q2 2025 Revenue Growth - TipRanks
Hinge Health's Q3 Revenue Exceeds Expectations, Shares Surge 10% - AInvest
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Es liegen keine Finanzdaten für Hinge Health Inc (HNGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):